Navigation Links
Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research
Date:9/2/2014

NEW YORK, September 2, 2014 /PRNewswire/ --

Persistence Market Research (http://www.persistencemarketresearch.com/) "Global Market Study on Membrane Technology in Pharmaceutical, Biopharma and Life Sciences: North America to Witness Highest Growth by 2019" the global membrane technology market for pharmaceutical, biopharma and life sciences is estimated at USD 7,029.9 million in 2014 and is expected to grow at a CAGR of 9.1% from 2014 to 2019, to reach an estimated value of USD 10,886.0 million in 2019.

Browse the full Global Market Study on Membrane Technology in Pharmaceutical, Biopharma and Life Sciences: North America to Witness Highest Growth by 2019 report at http://www.persistencemarketresearch.com/market-research/membrane-technology-market.asp

The membrane technology market in pharmaceutical, biopharma and life sciences is growing due to increased research and development and production in pharmaceutical, biopharmaceutical and life sciences industries. Moreover, stringent regulations and usage of single-use disposable technique are also playing a major role in growth of the membrane technology market. Presence of various filtration techniques such as ultrafiltration, nanofiltration and microfiltration under membrane technology has increased its acceptance in pharmaceutical, biopharmaceutical and life science industries for separation and purification of components and biomolecules, over conventional techniques. 

However, the market faces some restraints such as effects of membrane fouling, high operational and investment cost and limitation of membrane materials. As a result, the market is expected to grow at a CAGR of about 9.1% during 2014-2019. 

North America is the largest market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries. The U.S. is the world's largest market for pharmaceutical and biopharmaceutical products. According to the European Federation of Pharmaceutical Industries and Associations, North America accounted for about 41% of global pharmaceutical sales in 2012. 

Similarly, in Europe, membrane technology is a rapidly growing sector with many associations, organizations and societies actively involved in expansion and implementation of this technology in various industries including pharmaceutical, biopharmaceutical and life sciences. However, Asia is the fastest growing region in the membrane technology market due to continuous development in pharmaceutical and biopharmaceutical industries. 

Recent Published Market Reports by Persistence Market Research:  

The global microfluidic device market was valued at USD 1,531.2 million in 2013 and is expected to grow at a CAGR of 22.8% from 2013 to 2019, to reach an estimated value of USD 5,246.4 million in 2019.

The global home infusion therapy market is estimated at USD 15.9 billion in 2014 and is expected to reach USD 26.7 billion by 2020, growing at a CAGR of 9.0% from 2014 to 2020. 

The global flavored and functional water market was valued at USD 17.2 billion in 2012 and is expected to grow at a CAGR of 11.5% from 2013 to 2019, to reach an estimated value of USD 36.7 billion in 2019.

GE Healthcare Life Sciences and 3M are some of the leading players in the global membrane technology market in pharmaceutical, biopharma and life sciences. Other major players of the membrane technology market include Pall Corporation, Sartorius, Merck Millipore, Koch Membrane Systems Inc., Novasep, TriSep Corporation, Amazon Filters Ltd. and Advantec MFS.

The global market of membrane technology in pharmaceutical, biopharma and life sciences is segmented as follows:

Membrane Technology Market in Pharmaceutical, Biopharma and Life Sciences, By Technology 

  • Ultrafiltration
  • Microfiltration
  • Nanofiltration
  • Chromatography

Browse the full report With TOC at http://www.persistencemarketresearch.com/market-research/membrane-technology-market.asp

Membrane Technology Market in Pharamceutical, Biopharma and Life Sciences, by Geography 

  • North America
    • U.S.
  • Europe
    • Switzerland
    • Germany
    • Italy
    • U.K.
    • Ireland
    • France
  • Asia
    • China
    • India
    • Japan
    • Malaysia
    • Singapore
  • Rest of the World (RoW)

Latest Market Press Releases: http://www.persistencemarketresearch.com/media-releases.asp

About Us: 

Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

PMR stands committed to bringing more accuracy and speed to clients' business decisions. From ready-to-purchase market research reports to customized research solutions, PMR's engagement models are highly flexible without compromising on its deep-seated research values.

Contact Us:

Addie Thomas
305 Broadway
7th Floor
New York City, NY 10007, USA
Tel: No. +1-646-568-7751
USA - Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Market Survey Articles: http://www.persistencemarketresearch.com/articles.asp


'/>"/>
SOURCE Persistence Market Research
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. Oncothyreon to Present at Rodman & Renshaw Global Investment Conference
2. 9.8% CAGR for Oligonucleotide Synthesis Market Globally to 2019 Says a New Research Report Available at RnRMarketResearch.com
3. Epoxy Hardener Industry Development Trends in Global & China Regions Now Available at ReportsnReports.com
4. Global Orthobiologics Market to Reach $5,519.9 Million by 2019: Transparency Market Research
5. Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018
6. Global Biodegradable Packaging Materials Market 2014-2018
7. Global Chelating Agents Market 2014-2018
8. Global Lactic Acid (Biodegradable Polymer, Food & Beverage, Personal Care & Pharmaceutical) Market - Trends & Forecasts to 2019
9. Global Enzyme for Pulp & Paper Industry Report 2014
10. Global Stable Isotope Ratio Mass Spectrometer Industry Report 2014
11. AMRI CEO to Present at the Morgan Stanley Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... 2016  Spherix Incorporated (Nasdaq: SPEX ) -- an intellectual ... of intellectual property, today provided an update on the ... District of Texas and announcing ... Inter Partes Re-examination ("IPR") proceedings that VTech and ... was initiated on only certain claims of two of ...
(Date:2/3/2016)... DIEGO , Feb. 3, 2016   ... company with the first pluripotent stem cell-derived islet ... diabetes in clinical-stage development, today announced that ViaCyte ... Pharmaceutical Companies of Johnson & Johnson, have agreed ... group into ViaCyte.  The agreement provides ViaCyte with ...
(Date:2/3/2016)... NEW BRUNSWICK, N.J. , Feb. 3, 2016 ... 30 grants totaling more than $1 million for ... who are working on health-related research that demonstrates ... , this round of funding for the New ... available for faculty members at these educational institutions— ...
(Date:2/3/2016)... Feb. 3, 2016  Silk Therapeutics, Inc., today announced the ... Therapeutics has now raised a total of $10.25 million in ... company. The Series A2 round was led by existing investor ... with participation from new investors Lear Corporation and Highland Consumer ... P. Disney ; Richard Sackler , MD, with Summer ...
Breaking Biology Technology:
(Date:2/2/2016)... , Feb. 2, 2016  Based on ... Frost & Sullivan recognizes US-based Intelligent Retinal Imaging ... & Sullivan Award for New Product Innovation. IRIS, ... North America , is poised ... rapidly growing diabetic retinopathy market. The IRIS technology ...
(Date:2/1/2016)... 2016  Today, the first day of American Heart ... develop a first of its kind workplace health solution ... In the first application of Watson ... ), and Welltok will create a new offering that ... analytics, delivered on Welltok,s health optimization platform. The effort ...
(Date:1/28/2016)... SAN JOSE, Calif., Jan. 28, 2016 Synaptics (NASDAQ: ... financial results for its second quarter ended December 31, 2015. ... the second quarter of fiscal 2016 increased 2 percent compared to ... the second quarter of fiscal 2016 was $35.0 million, or $0.93 ... Non-GAAP net income for the first quarter of fiscal 2016 ...
Breaking Biology News(10 mins):